Dr. Kanwar is a Professor of Medicine at the University of Chicago and Director of their Heart Failure and Pulmonary Hypertension program. She currently serves as the Associate Editor for MCS for the Journal of Heart and Lung Transplantation. With nearly 200 peer-reviewed publications, her area of research focus includes outcomes research in cardiogenic shock, temporary and durable mechanical circulatory support, as well as pulmonary hypertension.

Muthiah Vaduganathan, MD MPH FACC FHFA is a cardiologist and clinical trialist at Brigham and Women’s Hospital and Harvard Medical School. He is co-director of the Center for Cardiometabolic Implementation Science at Brigham and Women’s Hospital. He serves as an Associate Editor of JACC and as US national ambassador to the ESC Heart Failure Association. His research focuses on drug development, clinical trials, and implementation of cardio-kidney-metabolic therapies. He has authored or co-authored more than 850 peer-reviewed publications and is recognized as a Clarivate Highly Cited Researcher. He participates on study leadership of ongoing advanced-phase trials in cardio-kidney-metabolism and heart failure.

Dr Erin Howden (PhD, 2012, University of Queensland) is a Heart Foundation Future Fellow and Group Leader of the Sports Cardiology Lab at the Baker Institute. Erin is an ESSA accredited Exercise Physiologist with extensive experience in conducting clinical exercise training studies focused on evaluating cardiovascular endpoints.